{"Title": "Deprescribing dementia drugs", "Year": 2020, "Source": "BMJ", "Volume": "368", "Issue": null, "Art.No": null, "PageStart": null, "PageEnd": null, "CitedBy": 0, "DOI": "10.1136/bmj.m650", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85079914072&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Dementia", "Deprescriptions", "France", "Humans"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-85079914072", "SubjectAreas": [["Medicine (all)", "MEDI", "2700"]], "AuthorData": {"57220420292": {"Name": "Iliffe S.", "AuthorID": "57220420292", "AffiliationID": "60022148", "AffiliationName": "Centre for Ageing Population Studies, University College London, Royal Free Campus"}, "57202296197": {"Name": "Manthorpe J.", "AuthorID": "57202296197", "AffiliationID": "60011520", "AffiliationName": "NIHR Health and Social Care Workforce Research Unit, King's College London"}}}